General Information of Drug (ID: DMH6XJG)

Drug Name
WCK-2349 Drug Info
Synonyms WCK-177 prodrug (MRSA infection), Wockhardt
Indication
Disease Entry ICD 11 Status REF
MRSA infection 1D01.0Y Phase 2 [1]
Cross-matching ID
PubChem CID
16734914
CAS Number
CAS 706809-20-3
TTD Drug ID
DMH6XJG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [3]
Levofloxacin DMS60RB Acute maxillary sinusitis Approved [3]
Gatifloxacin DMSL679 Acute gonococcal cervicitis Approved [3]
Ozenoxacin DM6KZMG Impetigo 1B72 Approved [4]
Sparfloxacin DMB4HCT Bacterial infection 1A00-1C4Z Approved [3]
Gemifloxacin DMHT34O Bacterial infection 1A00-1C4Z Approved [3]
Besifloxacin DMPHXMI Ocular inflammation 9C61.24 Approved [5]
Finafloxacin DMZEONG Urinary tract infection GC08 Approved [6]
Delafloxacin Meglumine DMVTU5Q Acute bacterial skin infection 1C41 Approved [7]
Moxifloxacin DMU8V4S Bacterial infection 1A00-1C4Z Approved [3]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Staphylococcus Topoisomerase IV (Stap-coc parC) TTIXTO3 PARC_STAAS Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038027)
2 DOI: 10.1038/ja.2013.86
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4 In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother. 2002 Mar;49(3):455-65.
5 Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
6 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
7 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.